Trial CTRI/2020/05/025369
Publication Soin AS, Lancet Respir Med, 2021
Primary outcome on the report: Proportion of patients with progression of COVID-19 from moderate to severe or from severe to death up to day 14

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.